Calycia Bioscience

Salt Lake City, United States · $400K raised

Employees
1–10
Business Model
B2B
Total Funding
$400K
Last Round
$400K Pre-SeedJan 2026
Rounds
1

About

CaLycia Bioscience is a Salt Lake City-based biotechnology company, spun out of the University of Utah, developing novel macrophage cell therapies. By leveraging the unique biology of macrophages, the company engineers cells designed to infiltrate, remodel, and treat aggressive solid tumors of the brain via local administration into the central nervous system, bypassing the blood-brain barrier. Its lead intracranial program, CALYM-001, targets glioblastoma, with a second program addressing melanoma brain metastasis.

Summary

Calycia Bioscience is a Biotech company based in Salt Lake City, United States. It has raised $400K in total across 1 round, most recently a $400K Pre-Seed round in Jan 2026. Investors include EPIC Ventures.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Pre-seedPre-SeedJan 2026
$400K

Investors

Similar Companies